Immuneering (IMRX) partners with Eli Lilly to test atebimetinib + olomorasib in a phase 2 trial targeting KRAS G12c-mutant ...

Immuneering to evaluate atebimetinib in combination with olomorasib in planned Phase 2 trial in patients with advanced non-small cell lung cancer – CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ...

Colorectal cancer (CRC) is a significant global health concern, originating from precancerous polyps in the colon or rectum and progressing through ...

Technology company Tempus AI has announced the acquisition of Paige, a company focused on digital pathology and AI, for a ...

An off-the-shelf cancer vaccine is associated with durable responses and a reduced risk of relapse and death among patients ...

The Methodist Church, Ghana, has commemorated its 190th anniversary celebration of its existence in Ghana with a grand durbar in Cape Coast, where the first society of the church was established ...

© 2001-2025 Plasteurope.com | Imprint | Privacy | Cookie settings ...